Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angeles Alvarez Secord

Showing results (51-60 of 239) with videos related to

Pageof 24
Sort By:
Obstetrics and Gynecology|August 2, 2008
Medical and surgical treatment of placenta percreta to optimize bladder preservationPaula S Lee, Ryan Bakelaar, C Brennan Fitpatrick, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 2, 2021
Adjuvant treatment and outcomes for patients with stage IIIA grade 1 endometrioid endometrial cancerMary Katherine Montes de Oca, Benjamin B Albright, Angeles Alvarez Secord, et al.
Practical Radiation Oncology|March 31, 2026
Molecular Classification Refines Adjuvant Radiation Therapy Use in Stage III Endometrial Cancer Exhibiting No Specific Molecular ProfileJeffery V Brower, Aine Clements, Junzo Chino, et al.
Journal of Cancer Research and Clinical Oncology|September 4, 2013
Autoantibody biomarkers identified by proteomics methods distinguish ovarian cancer from non-ovarian cancer with various CA-125 levelsAykan A Karabudak, Julie Hafner, Vivekananda Shetty, et al.
Gynecologic Oncology|July 21, 2004
The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancerAngeles Alvarez Secord, Robyn Sayer, Stacey A Snyder, et al.
Obstetrics and Gynecology|January 9, 2025
A New Way Forward for Women's Health Research at the National Institutes of Health: A Roadmap From the National Academies of Sciences, Engineering, and Medicine's Consensus ReportMichelle P Debbink, Methodius G Tuuli, Amy Geller, et al.
Gynecologic Oncology|June 25, 2003
The role of PET scanning in the detection of recurrent cervical cancerLaura J Havrilesky, Terence Z Wong, Angeles Alvarez Secord, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Role of endometrial sampling to differentiate between advanced endometrial versus ovarian malignancy: retrospective cohort studyNguyen Thao Thi Nguyen, Nicole Diaz, Hadley Reid, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 11, 2014
Dasatinib (BMS-35482) interacts synergistically with docetaxel, gemcitabine, topotecan, and doxorubicin in ovarian cancer cells with high SRC pathway activation and protein expressionAngeles Alvarez Secord, Deanna Teoh, Jingquan Jia, et al.
Gynecologic Oncology|May 23, 2012
Physical strain and urgent need for ergonomic training among gynecologic oncologists who perform minimally invasive surgeryJason Franasiak, Emily M Ko, Juli Kidd, et al.
Pageof 24

Showing results (51-60 of 239) with videos related to

Sort By:
Pageof 24
Obstetrics and Gynecology|August 2, 2008
Medical and surgical treatment of placenta percreta to optimize bladder preservationPaula S Lee, Ryan Bakelaar, C Brennan Fitpatrick, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 2, 2021
Adjuvant treatment and outcomes for patients with stage IIIA grade 1 endometrioid endometrial cancerMary Katherine Montes de Oca, Benjamin B Albright, Angeles Alvarez Secord, et al.
Practical Radiation Oncology|March 31, 2026
Molecular Classification Refines Adjuvant Radiation Therapy Use in Stage III Endometrial Cancer Exhibiting No Specific Molecular ProfileJeffery V Brower, Aine Clements, Junzo Chino, et al.
Journal of Cancer Research and Clinical Oncology|September 4, 2013
Autoantibody biomarkers identified by proteomics methods distinguish ovarian cancer from non-ovarian cancer with various CA-125 levelsAykan A Karabudak, Julie Hafner, Vivekananda Shetty, et al.
Gynecologic Oncology|July 21, 2004
The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancerAngeles Alvarez Secord, Robyn Sayer, Stacey A Snyder, et al.
Obstetrics and Gynecology|January 9, 2025
A New Way Forward for Women's Health Research at the National Institutes of Health: A Roadmap From the National Academies of Sciences, Engineering, and Medicine's Consensus ReportMichelle P Debbink, Methodius G Tuuli, Amy Geller, et al.
Gynecologic Oncology|June 25, 2003
The role of PET scanning in the detection of recurrent cervical cancerLaura J Havrilesky, Terence Z Wong, Angeles Alvarez Secord, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Role of endometrial sampling to differentiate between advanced endometrial versus ovarian malignancy: retrospective cohort studyNguyen Thao Thi Nguyen, Nicole Diaz, Hadley Reid, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 11, 2014
Dasatinib (BMS-35482) interacts synergistically with docetaxel, gemcitabine, topotecan, and doxorubicin in ovarian cancer cells with high SRC pathway activation and protein expressionAngeles Alvarez Secord, Deanna Teoh, Jingquan Jia, et al.
Gynecologic Oncology|May 23, 2012
Physical strain and urgent need for ergonomic training among gynecologic oncologists who perform minimally invasive surgeryJason Franasiak, Emily M Ko, Juli Kidd, et al.
Pageof 24